A Phase 1 AVB-S6-500 Safety and Tolerability Study
Clinical trial NCT03401528 · COMPLETED
Trial details
- NCT number
- NCT03401528
- Sponsor
- Aravive, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-31
- Primary completion
- 2018-06-20
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.